Edwards Lifesciences' Chairman and CEO to Exercise Stock Options Under 10b5-1 Stock Trading Plan
(firmenpresse) - IRVINE, CA -- (Marketwire) -- 05/07/12 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that in May 2012, its chairman and chief executive officer, Michael A. Mussallem, will begin exercising stock options that are near expiration under a pre-arranged stock trading plan under Rule 10b5-1 of the Securities and Exchange Act of 1934.
The plan, which Mussallem adopted in February 2012, will provide a vehicle for him to exercise Edwards stock options due to expire in April and May 2013, and provides for the exercise and sale of up to 35,000 shares per month. Under this plan, stock sales are intended to be spread evenly over an extended period of time. Rule 10b5-1 allows corporate executives to adopt stock trading plans to buy or sell shares of company stock when they are not in possession of material, non-public information. Mussallem plans to enter into similar types of trading plans each year as new stock options near their expiration dates.
Under the company's stock ownership guidelines, Mussallem is required to own shares of company stock with an aggregate market value equal to six times his base salary. At the conclusion of the plans, Mussallem will still hold shares well in excess of the number required to meet these guidelines. Transactions under these plans will be disclosed publicly through Form 144 and Form 4 filings with the U.S. Securities and Exchange Commission. The Form 4 filings will also be posted on Edwards' investor relations Web site at .
About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives. Additional company information can be found at .
Edwards, Edwards Lifesciences and the stylized E logo are trademarks of Edwards Lifesciences Corporation.
Amanda C. Fowler
949-250-5070
David K. Erickson
949-250-6826
One Edwards Way
Irvine, CA USA 92614
Phone: 949.250.2500
Fax: 949.250.2525
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 07.05.2012 - 07:00 Uhr
Sprache: Deutsch
News-ID 1111191
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
IRVINE, CA
Phone:
Kategorie:
Medical Devices
Anmerkungen:
Diese Pressemitteilung wurde bisher 93 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Edwards Lifesciences' Chairman and CEO to Exercise Stock Options Under 10b5-1 Stock Trading Plan
"
steht unter der journalistisch-redaktionellen Verantwortung von
Edwards Lifesciences (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
